Draft:Matt Cooper (scientist)

From Wikipedia, the free encyclopedia

Matt Cooper is an Australian scientist and researcher focused on platform technologies, clinical diagnostics, therapeutics for inflammatory, autoimmune, and infectious diseases.[1][2][3]

Education[edit]

Cooper completed his BSc and PhD in Organic chemistry in 1995 at the University of Adelaide, Australia.[4][5] He then worked at the University of Cambridge, where he worked on biosensors and molecular recognition.[6][7]

Career[edit]

He has focused on interactions of ligands with membrane receptors.[8]

He returned to Australia with a National Health and Medical Research Council (NHMRC) Australia Fellowship at the University of Queensland, where he founded the Center for Superbug Solutions, Community for Open Access Antibiotic Discovery (CO-ADD), and Center for Drug Discovery and Design.[9][2][10]

He is the founder of Sitala, a biotech company focused on blocking harmful inflammation linked to Parkinson's disease.[11] Along with Luke O'Neill, he co-founded Inflazome, which was sold to Roche in September 2020 for AUS$620 million.[12][3][13]

References[edit]

  1. ^ Forbion. "Matt Cooper". Forbion. Retrieved 2023-12-21.
  2. ^ a b "Professor Matt Cooper". CO-ADD.
  3. ^ a b "Prof. Matt Cooper, FRSC – Non-Executive Director". Gertrude Biomedic. Retrieved 2023-12-21.
  4. ^ "Queensland Academy of Arts and Sciences – Matt Cooper". www.qldacademy.org.au. Retrieved 2023-12-21.
  5. ^ "Matthew Cooper". The Conversation. 2011-04-28. Retrieved 2023-12-21.
  6. ^ Cooper, Matthew A., ed. (2009). Label-Free Biosensors: Techniques and Applications. Cambridge: Cambridge University Press. doi:10.1017/CBO9780511626531. ISBN 978-0-521-88453-2.
  7. ^ Nature, Research Communities by Springer (2018-01-16). "Bacterial membrane targeting to improve antibiotic activity". Research Communities by Springer Nature. Retrieved 2023-12-21.
  8. ^ "Supertiny sensors could improve antibiotics in the fight against superbugs". CNET. Retrieved 2023-12-21.
  9. ^ "NHMRC awards more than $11 million to IMB research". imb.uq.edu.au. 2015-11-09. Retrieved 2023-12-21.
  10. ^ Forbion (2022-07-20). "Forbion appoints Dr. Peter Høngaard Andersen as Operating Partner and Dr. Matt Cooper as Venture Partner". Forbion. Retrieved 2023-12-21.
  11. ^ "Sitala". Shake It Up Australia Foundation. Retrieved 2023-12-21.
  12. ^ "Prof Matt Cooper: 'it's not about the money; it's about the patients'". The Irish Times. Retrieved 2023-12-21.
  13. ^ "The Irish Times Business Person of the Month: Matt Cooper". The Irish Times. Retrieved 2023-12-21.


Category:Living people Category:Fellows of the Royal Society Category:Scientists from Adelaide Category:University of Adelaide alumni Category:Year of birth missing (living people)

Retrieved from "https://en.wikipedia.org/w/index.php?title=Draft:Matt_Cooper_(scientist)&oldid=1205860073"